THE IMPACT OF EARLY TREATMENT WITH ADALIMUMAB ON RHEUMATOID FACTOR AND ANTI-CITRULLINATED PEPTIDE ANTIBODY LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE OPTIMA TRIAL

被引：1
|
作者：
Smolen, J. S. [1 ]
Kavanaugh, A. [2 ]
Aletaha, D. [1 ]
Florentinus, S. [3 ]
Li, Y. [3 ]
Lagunes, I. [3 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] AbbVie, N Chicago, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1311
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0135
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [21] ANTI-CITRULLINATED PEPTIDE ANTIBODIES AND RHEUMATOID FACTOR TESTING PATTERNS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN THE US
    An, J.
    Lin, A.
    Bider, Z.
    Alemao, E.
    Connolly, S. E.
    Cheetham, T. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1245 - 1246
  • [22] Clinical Implications of Shared Epitope and Anti-citrullinated Peptide Antibody in Patients With Rheumatoid Arthritis
    Jung, Seung Min
    Park, Yune-Jung
    Park, Kyung-Su
    Kim, Ki-Jo
    JOURNAL OF RHEUMATIC DISEASES, 2022, 29 (03): : 171 - 180
  • [23] Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients
    Viatte, Sebastien
    Plant, Darren
    Bowes, John
    Lunt, Mark
    Eyre, Stephen
    Barton, Anne
    Worthington, Jane
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (12) : 1984 - 1990
  • [24] ASSOCIATION OF RHEUMATOID FACTOR AND ANTI-CITRULLINATED PROTEIN ANTIBODY STATUS WITH ORTHOPEDIC SURGERIES FOR RHEUMATOID ARTHRITIS PATIENTS
    Mizuki, S.
    Higashioka, K.
    Yoshida, K.
    Oryoji, K.
    Kamada, K.
    Yokota, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 998 - 998
  • [25] Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive
    Hiwa, Ryosuke
    Ohmura, Koichiro
    Nakabo, Shuichiro
    Terao, Chikashi
    Murakami, Kosaku
    Nakashima, Ran
    Imura, Yoshitaka
    Yukawa, Naoichiro
    Yoshifuji, Hajime
    Hashimoto, Motomu
    Furu, Moritoshi
    Ito, Hiromu
    Fujii, Takao
    Mimori, Tsuneyo
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (06) : 731 - 736
  • [26] Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor
    Vander Cruyssen, B
    Peene, I
    Cantaert, T
    Hoffman, IEA
    De Rycke, L
    Veys, EM
    De Keyser, F
    AUTOIMMUNITY REVIEWS, 2005, 4 (07) : 468 - 474
  • [27] IgM Rheumatoid Factor As a Potentiator Of Anti-Citrullinated Protein Antibody Mediated Inflammation In Rheumatoid Arthritis
    Sokolove, Jeremy
    Cheng, Danye
    Johnson, Dannette S.
    Mikuls, Ted R.
    Robinson, William H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S343 - S344
  • [28] RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS DIFFERS DEPENDING ON RHEUMATOID FACTOR LEVELS IN ANTI-CITRULLINATED POSITIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Bugatti, S.
    Manzo, A.
    Zanframundo, G.
    Benaglio, F.
    Sakellariou, G.
    Montecucco, C.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 790 - 791
  • [29] Development of anti-citrullinated protein antibody and rheumatoid factor isotypes prior to the onset of rheumatoid arthritis
    Bos, Wouter H.
    van de Stadt, Lotte A.
    Sohrabian, Azita
    Ronnelid, Johan
    van Schaardenburg, Dirkjan
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (02)
  • [30] Development of anti-citrullinated protein antibody and rheumatoid factor isotypes prior to the onset of rheumatoid arthritis
    Wouter H Bos
    Lotte A van de Stadt
    Azita Sohrabian
    Johan Rönnelid
    Dirkjan van Schaardenburg
    Arthritis Research & Therapy, 16
12345